The pharma giant said amycretin helped patients lose weight and reduce blood-sugar levels in pill and injection forms during ...

Previous mega blockbusters took years to reach their peak sales. Lilly’s tirzepatide franchise is on course to exceed them ...

Bernstein just threw fresh fuel on Eli Lilly’s ( LLY) never-ending rally, as the firm lifted its price target on the stock to ...

Oscilloscope Laboratories has acquired “John Lilly and the Earth Coincidence Control Office,” a documentary about a daring ...

Novo Nordisk stock was rebounding Tuesday. It’s a tale of two drug trials.The Danish pharmaceutical giant said its new ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.

A next-generation treatment from Novo Nordisk helped patients with diabetes lower their blood sugar and lose weight in a ...

SAN DIEGO, Nov. 25, 2025 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Dr.

Novo Nordisk’s amycretin showed no weight-loss plateau over 36 weeks in patients with type 2 diabetes, suggesting its efficacy could become even stronger with longer follow-up, according to analysts ...

David Gallagher has been charged with the murder of his mother and with assault causing harm to his father, close to the ...

Overview NVIDIA, Iren, and IonQ look very well positioned with powerful exposure to AI, high-performance computing, and ...